The Breast Cancer Susceptibility Gene Product (γ-Synuclein) Alters Cell Behavior through its [corrected] Interaction with Phospholipase Cβ

Cell Signal. 2016 Jan;28(1):91-9. doi: 10.1016/j.cellsig.2015.10.018. Epub 2015 Oct 28.

Abstract

The breast cancer susceptibility gene protein, also known as γ-synuclein, is highly expressed in human breast cancer in a stage-specific manner, with highest expression in late stage cancer. In model systems, γ-synuclein binds phospholipase Cβ2 which is regulated by Gαq to generate intracellular Ca(2+) signals. PLCβ2, which is also absent in normal tissue but highly expressed in breast cancer, is additionally regulated by Rac to promote migration pathways. We have found that γ-synuclein binds to the same region of PLCβ2 as Gαq. Using cells that mimic stage 4 breast cancer (MDA MB 231), we show that down-regulation of γ-synuclein reduces the protein level of PLCβ but increases the transcript level over 40 fold. γ-Synuclein down-regulation also promotes the interaction between Gαq and PLCβ resulting in a stronger Ca(2+) response to Gαq agonists. The ability of γ-synuclein to interfere with Gαq-PLCβ interactions allows more PLCβ to colocalize with Rac impacting Rac-mediated pathways that may give rise to cancerous phenotypes.

Keywords: Calcium signaling; Cell migration; Cell morphology; Phospholipase Cβ2; γ-Synuclein.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Cell Line, Tumor
  • Cell Movement / physiology*
  • Down-Regulation
  • Female
  • GTP-Binding Proteins / metabolism
  • Humans
  • Oncogene Proteins / metabolism
  • Phospholipase C beta / metabolism*
  • gamma-Synuclein / genetics
  • gamma-Synuclein / metabolism*

Substances

  • Oncogene Proteins
  • gamma-Synuclein
  • Phospholipase C beta
  • GTP-Binding Proteins